Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 25, 2013

View Archived Issues

Abcodia licenses algorithm for the diagnosis of ovarian cancer

AstraZeneca reports on discovery of a novel DNA gyrase inhibitor: NBTI-5463

Small-molecule mediated activation of cell signaling to increase hematopoietic stem cell expansion

Retrophin makes new proposal to acquire Transcept

EpimiRNA Consortium receives funding to study microRNA therapeutics in epilepsy

Study of CPX-351 in pediatric and young adults commences

Researchers test H7N9 avian influenza vaccine candidate

Carboxy-terminal fragment of CPE shows potential in imaging treatment-resistant ovarian cancer

Kineret receives positive CHMP opinion for cryopyrin-associated periodic syndromes

Isis Pharmaceuticals reports phase II ISIS-APOCIIIRx data in familial chylomicronemia

Dual bronchodilator Ultibro inhalation capsules approved in Europe for COPD

Stelara obtains FDA approval for active psoriatic arthritis

A local inhibitor of ROCK prevents corneal scarring and neovascularization in vivo

Takeda obtains European approval for three new type 2 diabetes therapies

First patient treated with NTCell regenerative cell therapy for Parkinson's disease

NIH funding boosts new Alzheimer's disease research

EC approves Revolade in chronic hepatitis C-associated thrombocytopenia

CHMP issues positive opinion for PSD-502 in premature ejaculation

BioMarin begins dosing in phase I/II trial of enzyme replacement therapy for Batten disease

FDA issues complete response letter for sugammadex

EMA committee recommends approval of Cimzia in new indication

Researchers in Russia patent novel antifungal agents

Nampt inhibitors jointly reported by FORMA Therapeutics and Genentech

Northwestern University divulges agents for S. pneumoniae infections

Boehringer Ingelheim and Vitae Pharmaceuticals patent BACE1 inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...